30.04.2025
| Corporate Action Details | |
|---|---|
| Corporate Action Reference | 1030029 |
| Corporate Action Type Code | MEET |
| Corporate Action Type | Annual General Meeting |
| Planned Corporate Action Date | 23 may 2025 10:00 Moscow time |
| Record Date | 29 april 2025 |
| Meeting Form | in the form of meeting |
| Meeting Location | Самарская обл., г. Тольятти, ул. Комзина, д. 6. (Большой концертный за л) |
| Security Details | |||||||
|---|---|---|---|---|---|---|---|
| Corporate Action Security Reference | Issuer | Registration Number | Date of Registration | Сategory | NSD Code | ISIN | |
| 1030029X81946 | PJSC "Ozon Pharmaceuticals" | 1-01-10877-P | 15 march 2024 | ordinary shares | RU000A109B25 | RU000A109B25 | |
| Linked Corporate Actions | ||
|---|---|---|
| Corporate Action Type Code | Corporate Action Reference | |
| DVCA | 1033889 | |
The information regarding general meeting of shareholders has been received by NSD
EDI. In order to inform legal entities and individuals entitled to participate in
the corporate action event, the received information will be sent to the deponents,
who has balances on the record date of the event in the owner, nominee or beneficial
owner safekeeping accounts, via NSD EDI system according to Federal Law On Joint-Stock
Companies No. 208-FZ dated 26.12.1995 (Article 52, i.9). In case of inability of receipt
of the information via NSD EDI system deponents can receive the information at the
NSD office.
NSD shall not be liable for completeness and/or accuracy of information provided by
the third parties.
If you have any questions related to this communication, please contact your account managers at NSD by telephone: +7 495 956-27-90 or +7 495 956-27-91.